2Wong K A, Lodish HF. A revised model for AMP structure: The alpha- subunit binds to both the beta - and gamma - subunits but there is no direct binding between the beta - and gamma - subunits[J]. J Biol Chem, 2006, 281 : 36434 - 36442.
3Hawley S, Pan DA, Mustard KJ, et al. Calmodulin - dependent protein kinase kinase - betais an alternative upstream kinase for AMP - activated protein kinase[ J ]. Cell Metab, 2005, 2 : 9 - 19.
4Hardie D. The AMP - activated protein kinase cascade: the key sensor of cellularenergy status[J ]. Endocrinology, 2003, 144:5179 -5183.
6Wright D, Geiger P, Holloszy J, et al. Contraction - and hypoxia - stimulated glucose transport is mediated by a Ca^2 + - dependent mechanism in slowtwitch rat soleus muscle[J]. AM J Physiol M, 2005, 288 : E1 062 - E1 066.
7Fujii N, Hirshman MF, Kahe EM, et al. AMP - activated protein kinase α2 activity is not essential for contraction - and hyperosmolarity- induced glucose transport in. skeletal muscle [ J ]. J Biol Chem, 2005, 80:39 033 - 39 041.
8Dana S Hutchinson, Tore Bengtsson. AMP - activated protein kinase activation by adrenoceptors in L6 skeletal muscle cells[J]. Diabetes. 2006.55,682 - 690.
9AndreeUi F, Foretz M, Knauf C, et al. Liver adenosine monophosphate - activated kinase - alpha2, catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not by insulin[J]. Endocrinology, 2006, 147:2432 - 2441.
10Shaw R, Lamia K, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin [J]. Science, 2005, 310:1642 - 1646.
2Gaasenbeek M, Powell BL, Sovio U, et al, Large-Scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone [J].J Clin Endocrinol Metab, 2004, 89 (5) : 2408-2413.
3Halkerston I, Eichhom J, Heehter O. A requirement for reduced triphosphopyridine nucleotide for cholesterol side-chain cleavage by mitochondrial fractions of bovine adrenal cortex [J]. J Biol Chem,1961,236 : 374.
4Neda Gharani DM, Waterworth SB, Davinia White CS, et al. Association of the steroid synthesis gene CYPlla with polycystic ovary syndrome and hyperandrogenism [J]. Human Molecular Genetics,1997, 6(3) :397-402.
5Evanthia DK, Michael IB, Angeliki T, et al. Microsatellite polymorphism (tttta)n at 2528 base pairs of gene CYP11a influences hyperandrogenemia in patients with polycystic ovary syndrome[J].Fertil and Steril, 2000, 73(4) :735-741.
6Kero JT, Savontaus E, Mikola M, et al. Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion[J].Am J Physiol Endocrinol Metab, 2003, 285 : E812-8,.
7Jose L, San M, Jose S, Rosa M, et al. Role of the pentanucleotide(tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism [J]. Fertil and Steril, 2001, 75 (4):797-802.
8Mendelson CR, Means GD, Mahendro MS, et al. Use of molecular probes to study regulation of aromatase cytochrome P-450 [J]. Biol ReDrod. 1990, 42:1 - 10.
9Blankenstein M A, Vande Ven J, Maitimu-smeele I, et al. Intratumoral levels of estrogens in breast cancer [ J ]. J Steroid Bioehem mol Biol,1999, 69,293 - 297.
10Arvanitis DA, Koumantakis GE, Goumenou AG, et al. CYP1A1,CYP19, and GSTM1 polymorphisms increase the risk of endometriosis[J]. Fertil Steril, 2003, 79 ( 1 ) : 702 - 709.
